Finance

Lists
600085:SHA
Beijing Tong Ren Tang Co Ltd
CNÂ¥24.14
+1.17%
(+0.28) 1D
Sep 4, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600085...
Open
CNÂ¥23.89
High
CNÂ¥24.29
Low
CNÂ¥23.85
Mkt. cap
33.11B
Avg. vol.
7.99M
Volume
5.72M
Dividend
2.07%
Quarterly dividend
CNÂ¥0.13
Ex-dividend date
Jul 1, 2026
P/E ratio
34.13
52-wk high
CNÂ¥35.87
52-wk low
CNÂ¥21.87
EPS
CNÂ¥0.71
Shares outstanding
1.37B
No. of employees
17K
Open
CNÂ¥23.89
High
CNÂ¥24.29
Low
CNÂ¥23.85
Mkt. cap
33.11B
Avg. vol.
7.99M
Volume
5.72M
Dividend
2.07%
Quarterly dividend
CNÂ¥0.13
Ex-dividend date
Jul 1, 2026
P/E ratio
34.13
52-wk high
CNÂ¥35.87
52-wk low
CNÂ¥21.87
EPS
CNÂ¥0.71
Shares outstanding
1.37B
No. of employees
17K
Profile
Tong Ren Tang is a Chinese pharmaceutical company founded in 1669. It is now the largest producer of traditional Chinese medicine. The company headquarters are in Beijing, where they engage in both manufacturing and retail sales. It operates drug stores, predominantly in Chinese-speaking regions. Tong Ren Tang is considered one of the "Big 4" traditional Chinese medicine brands still in existence. The four companies include: Guangyuyuan, Guangzhou Chen Liji, Beijing Tong Ren Tang, and Hangzhou Hu Qing Yu Tang. Tong Ren Tang, and GuangYuYuan have been officially recognized as "China Time-Honored Brands" by the Ministry of Commerce of the People's Republic of China. Wikipedia
About Beijing Tong Ren Tang Co Ltd
CEO-
Employees17.3K
Founded1669
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.54B
3.95B
4.66B
3.72B
Cost of goods sold
1.97B
2.50B
2.72B
2.17B
Cost of revenue
1.97B
2.50B
2.72B
2.17B
Research and development expenses
53.41M
144.52M
51.64M
74.50M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.10B
1.30B
1.13B
1.04B
Operating expense
1.16B
1.52B
1.23B
1.16B
Total operating expenses
3.13B
4.02B
3.95B
3.33B
Operating income
408.67M
-73.33M
709.73M
383.76M
Other non operating income
-3.64M
-4.50M
-3.96M
-4.53M
EBT including unusual items
346.57M
67.54M
748.37M
431.21M
EBT excluding unusual items
418.62M
-56.72M
750.60M
414.06M
Income tax expense
88.79M
27.32M
131.64M
112.60M
Effective tax rate
25.62%
40.44%
17.59%
26.11%
Other operating expenses
-1.80M
58.15M
29.98M
47.32M
Net income
232.06M
11.82M
471.18M
255.01M
Net profit margin
6.56%
0.30%
10.10%
6.86%
Earnings per share
-
-
-
-
Interest and investment income
45.55M
48.93M
70.91M
59.45M
Interest expense
-30.03M
-28.19M
-26.08M
-24.57M
Net interest expenses
15.52M
20.74M
44.83M
34.88M
Depreciation and amortization charges
-
-
-
-
EBITDA
495.57M
18.15M
801.21M
477.52M
Gain or loss from assets sale
1.87M
-25.11M
-
-10.41M
AI content may include mistakes. Learn more
Google apps